A future for hyperthermia in cancer treatment?

Editorial

O S Nielsen et al. Eur J Cancer. 2001 Sep.

. 2001 Sep;37(13):1587-9.

doi: 10.1016/s0959-8049(01)00193-9.

No abstract available

Comment on

Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study.
Issels RD, Abdel-Rahman S, Wendtner C, Falk MH, Kurze V, Sauer H, Aydemir U, Hiddemann W. Issels RD, et al. Eur J Cancer. 2001 Sep;37(13):1599-608. doi: 10.1016/s0959-8049(01)00183-6. Eur J Cancer. 2001. PMID: 11527684 Clinical Trial.
Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia.
Wendtner C, Abdel-Rahman S, Baumert J, Falk MH, Krych M, Santl M, Hiddemann W, Issels RD. Wendtner C, et al. Eur J Cancer. 2001 Sep;37(13):1609-16. doi: 10.1016/s0959-8049(01)00191-5. Eur J Cancer. 2001. PMID: 11527685 Clinical Trial.